JetBlue Airways (NASDAQ:JBLU), New York’s Hometown Airline, today announces its seventh annual “One Thing That’s Green” (OTTG) campaign. JetBlue Airways Corporation (NASDAQ:JBLU) shares after opening at $9.09 moved to $9.10 on last trade day and at the end of the day closed at $8.76. Company price to sales ratio in past twelve months was calculated as 0.48 and price to cash ratio as 4.13. JetBlue Airways Corporation (NASDAQ:JBLU) showed a positive weekly performance of 4.04%.
American Airlines Group (NASDAQ:AAL)‘s stock had its “buy” rating reaffirmed by analysts at Goldman Sachs in a research report issued to clients and investors on Monday, Analyst Ratings Net reports. They currently have a $46.00 price objective on the stock. Goldman Sachs’ price objective points to a potential upside of 25.82% from the stock’s previous close. American Airlines Group Inc. (NASDAQ:AAL) shares fell -2.09% in last trading session and ended the day on $36.56. AAL return on equity ratio is recorded as 33.60% and its return on assets is -7.70%. American Airlines Group Inc. (NASDAQ:AAL) yearly performance is 132.57%.
Select Medical Holdings (NYSE:SEM) was upgraded by investment analysts at RBC Capital from a “sector perform” rating to an “outperform” rating in a note issued to investors on Monday, Analyst Ratings Network.com reports. The firm currently has a $21.00 target price on the stock, up from their previous target price of $9.00. RBC Capital’s price target indicates a potential upside of 78.27% from the stock’s previous close. Select Medical Holdings Corporation (NYSE:SEM) shares moved down -1.79% in last trading session and was closed at $12.59, while trading in range of $12.57 – $13.03. Select Medical Holdings Corporation (NYSE:SEM) year to date (YTD) performance is 9.38%.
One such stock that you may want to consider dropping is Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. Agios Pharmaceuticals Inc. (NASDAQ:AGIO) weekly performance is -4.16%. On last trading day company shares ended up $35.48. Agios Pharmaceuticals Inc. (NASDAQ:AGIO) distance from 50-day simple moving average (SMA50) is 2.43%. Analysts mean target price for the company is $49.00.